RE:Asco Gu abstract releasedAs expected, based on the deadline for abstract submission back in Oct. The abstract reports.
| Assessment | 90 Day | 180 Day | 270 Day | 360 Day | 450 Day |
| CR | 50% | 47% | 41% | 35% | 21% |
| IR | 16% | 26% | 22% | 12% | 13% |
| Total Response | 66% | 74% | 63% | 46% | 33% |
| Evaluable Patients | 38 | 34 | 32 | 26 | 24 |
Whereas the Nov 29 data release, was:
Assessment 90 Day 180 Day 270 Day 360 Day 450 Day
Complete Response (“CR”) 53% 45% 41% 29% 28%
Indeterminate Response (“IR”) 14% 24% 19% 15% 10%
Total Response (“CR + IR”) 67% 69% 60% 44% 38%
Evaluable Patients 43 38 37 34 29
So the abscract summary is not as curret as the TLT data releases are.
The poster itself is where the interesting specific will be reported so that is what I'm looking forward to. For example, it may be the first ever clear display of the patients compared to TLT's releases.
I had a glance at the rest of the abstracts with key word NMIBC and there doesn't seem to be anythig earthshattering by way of competitors with other data.